ADVISE
-
Bayer Schering Kicks Off Antihypertensive Study in Asia
Bayer Schering Pharma has held two investigators meetings in Beijing, China and Seoul, Korea to announce the start of ADVISE, the Asia Pacific trial – nifeDipine in combination with Valsartan to achIeve blood preSsure targEts, a major phase IV stud…
ADVISE | 27 January 2010
